Suppr超能文献

心力衰竭患者如何以及何时使用肺部超声?

How and When to Use Lung Ultrasound in Patients with Heart Failure?

作者信息

Coiro Stefano, Rastogi Tripti, Girerd Nicolas

机构信息

Cardiology Department, Santa Maria della Misericordia Hospital, 06129 Perugia, Italy.

Centre D'Investigation Clinique-Plurithématique Inserm CIC-P 1433, Inserm U1116, CHRU Nancy Hopitaux de Brabois, Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Université de Lorraine, 54500 Vandoeuvre lès Nancy, France.

出版信息

Rev Cardiovasc Med. 2022 May 30;23(6):198. doi: 10.31083/j.rcm2306198. eCollection 2022 Jun.

Abstract

Pulmonary congestion is a critical finding in patients with heart failure (HF) that can be quantified by lung ultrasound (LUS) through B-line quantification, the latter of which can be easily measured by all commercially-available probes/ultrasound equipment. As such, LUS represents a useful tool for the assessment of patients with both acute and chronic HF. Several imaging protocols have been described in the literature according to different clinical settings. While most studies have been performed with either the 8 or 28 chest zone protocol, the 28-zone protocol is more time-consuming while the 8-zone protocol offers the best trade-off with no sizeable loss of information. In the acute setting, LUS has excellent value in diagnosing acute HF, which is superior to physical examination and chest X-ray, particularly in instances of diagnostic uncertainty. In addition to its diagnostic value, accumulating evidence over the last decade (mainly derived from ambulatory settings or at discharge from an acute HF hospitalisation) suggests that LUS can also represent a useful prognostic tool for predicting adverse outcome in both HF with reduced (HFrEF) and preserved ejection fraction (HFpEF). It also allows real-time monitoring of pulmonary decongestion during treatment of acute HF. Additionally, LUS-guided therapy, when compared with usual care, has been shown to reduce the risk of HF hospitalisations at short- and mid-term follow-up. In addition, studies have shown good correlation between B-lines during exercise stress echocardiography and invasive, bio-humoral and echocardiographic indices of haemodynamic congestion; B-lines during exercise are also associated with worse prognosis in both HFrEF and HFpEF. Altogether, LUS represents a reliable and useful tool in the assessment of pulmonary congestion and risk stratification of HF patients throughout their entire journey (i.e., emergency department/acute settings, in-hospital management, discharge from acute HF hospitalisation, monitoring in the outpatient setting), with considerable diagnostic and prognostic implications.

摘要

肺充血是心力衰竭(HF)患者的一项关键表现,可通过肺部超声(LUS)进行B线定量分析来量化,所有市售探头/超声设备均可轻松测量B线。因此,LUS是评估急性和慢性HF患者的有用工具。根据不同临床情况,文献中描述了几种成像方案。虽然大多数研究采用8区或28区胸部方案,但28区方案耗时更长,而8区方案在信息损失不大的情况下提供了最佳权衡。在急性情况下,LUS在诊断急性HF方面具有卓越价值,优于体格检查和胸部X线检查,尤其是在诊断不确定的情况下。除了其诊断价值外,过去十年积累的证据(主要来自门诊环境或急性HF住院出院时)表明LUS还可作为预测射血分数降低的心力衰竭(HFrEF)和射血分数保留的心力衰竭(HFpEF)不良结局的有用预后工具。它还能在急性HF治疗期间实时监测肺充血的缓解情况。此外,与常规护理相比,LUS引导的治疗已被证明可降低短期和中期随访中HF住院的风险。此外,研究表明运动应激超声心动图期间的B线与血流动力学充血的侵入性、生物体液和超声心动图指标之间具有良好的相关性;运动期间的B线在HFrEF和HFpEF中也与更差的预后相关。总之,LUS是评估HF患者整个病程(即急诊科/急性情况、住院管理、急性HF住院出院、门诊监测)中肺充血和风险分层的可靠且有用的工具,具有重要的诊断和预后意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d70f/11273962/adad0668f663/2153-8174-23-6-198-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验